- Home
- DDOG vs EW Comparison
DDOG vs EW Comparison
Compare DDOG & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDOG
- EW
- Stock Information
- Founded
- DDOG 2010
- EW 1958
- Country
- DDOG United States
- EW United States
- Employees
- DDOG N/A
- EW N/A
- Industry
- DDOG Computer Software: Prepackaged Software
- EW Industrial Specialties
- Sector
- DDOG Technology
- EW Health Care
- Exchange
- DDOG Nasdaq
- EW Nasdaq
- Market Cap
- DDOG 47.3B
- EW 42.5B
- IPO Year
- DDOG 2019
- EW 2000
- Fundamental
- Price
- DDOG $138.40
- EW $69.78
- Analyst Decision
- DDOG Strong Buy
- EW Buy
- Analyst Count
- DDOG 30
- EW 21
- Target Price
- DDOG $157.83
- EW $78.48
- AVG Volume (30 Days)
- DDOG 3.3M
- EW 4.9M
- Earning Date
- DDOG 02-11-2025
- EW 02-04-2025
- Dividend Yield
- DDOG N/A
- EW N/A
- EPS Growth
- DDOG N/A
- EW 193.69
- EPS
- DDOG 0.52
- EW 6.89
- Revenue
- DDOG $2,536,197,000.00
- EW $6,314,900,000.00
- Revenue This Year
- DDOG $27.52
- EW N/A
- Revenue Next Year
- DDOG $21.67
- EW $1.06
- P/E Ratio
- DDOG $267.42
- EW $26.91
- Revenue Growth
- DDOG 26.30
- EW 24.02
- 52 Week Low
- DDOG $98.80
- EW $58.93
- 52 Week High
- DDOG $170.08
- EW $96.12
- Technical
- Relative Strength Index (RSI)
- DDOG 41.14
- EW 36.55
- Support Level
- DDOG $134.72
- EW $68.24
- Resistance Level
- DDOG $144.48
- EW $72.10
- Average True Range (ATR)
- DDOG 3.36
- EW 1.55
- MACD
- DDOG -0.98
- EW -0.66
- Stochastic Oscillator
- DDOG 28.51
- EW 19.27
About DDOG Datadog Inc.
Datadog is a cloud-native company that focuses on analyzing machine data. The firm's product portfolio, delivered via software as a service, allows a client to monitor and analyze its entire IT infrastructure. Datadog's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to utilize it for a variety of applications throughout their businesses.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.